Minerva Surgical

IPO

The Uterine Health Company.

Public · Redwood City, United States · Founded 2008

Employees
51–200
Founded
2008
Business Model
B2B
Last Round
Private EquityFeb 2023
Rounds
5
Type
Public

About

Minerva Surgical is a women's health medical device company singularly focused on minimally invasive intrauterine treatments for abnormal uterine bleeding (AUB). The company's product suite includes the Minerva Endometrial Ablation System, which uses three simultaneous ablation methods (bipolar RF energy, direct thermal ablation, and heated intracavitary fluids); the Symphion operative hysteroscopy system for fibroid and polyp removal; the Genesys HTA system offering continuous direct visualization; the Resectr tissue resection device; and the HERizon disposable hysteroscope for in-office diagnostic hysteroscopy. In January 2026, Axora Medical purchased the business assets of Minerva Surgical, with day-to-day operations remaining unchanged.

Summary

Minerva Surgical is a Femtech company based in Redwood City, United States, founded in 2008. Its most recent funding was a Private Equity round in Feb 2023. Investors include Accelmed Partners and New Enterprise Associates.

Tech & App Stack

6 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Private EquityPrivate EquityFeb 2023

Sign up to see all 6 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies